Document Detail

Apparent stimulation of thrombopoesis with interleukin-3 (IL-3) in chemotherapy induced myelosuppression.
MedLine Citation:
PMID:  8722119     Owner:  NLM     Status:  MEDLINE    
Two patients with advanced ovarian cancer (FIGO III C) and one patient with abdominal cancer developed severe thrombocytopenia with petechial haemorrhages after chemotherapy. These patients were treated with recombinant human interleukin-3 (rhIL-3) after multiple platelet transfusions (HLA-matched) and erythrocyte transfusions had not been effective. Increase of thrombocyte counts began three days after rhIL-3 therapy. Side effects due to rhIL-3 administration (flu-like symptoms) were moderate and could be treated effectively with paracetamol. These data support evidence for efficacy of rhIL-3 in chemotherapy-induced thrombocytopenia and may open new therapeutic perspectives.
C Schweiger; L Färber; G Füchsel; D Heinrich; W Meinerz
Related Documents :
11441929 - What is cancer chemotherapy?
17012839 - A novel non-invasive biomarker for assessment of small intestinal mucositis in children...
11536419 - Who wants second-line, palliative chemotherapy?
20856699 - Office-based intraperitoneal chemotherapy for ovarian cancer.
2196729 - Management of complications of cancer chemotherapy.
9114829 - Transverse leukonychia in patients receiving cancer chemotherapy.
16460599 - Compatibility and stability of the novel anti-cancer agent c1311 in infusion devices an...
24861849 - From the table to the bedside: can food-derived sulforaphane be used as a novel agent t...
7989499 - Ovarian cyst formation in two pre-menopausal patients treated with tamoxifen for breast...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  BioFactors (Oxford, England)     Volume:  5     ISSN:  0951-6433     ISO Abbreviation:  Biofactors     Publication Date:    1995-1996
Date Detail:
Created Date:  1997-01-17     Completed Date:  1997-01-17     Revised Date:  2006-07-19    
Medline Journal Info:
Nlm Unique ID:  8807441     Medline TA:  Biofactors     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  73-4     Citation Subset:  IM    
Sandoz AG, Clinical Research, Abt. KFO, Nuremberg, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Abdominal Neoplasms / complications,  drug therapy*
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Bone Marrow / drug effects*
Interleukin-3 / adverse effects*
Ovarian Neoplasms / complications,  drug therapy*
Stimulation, Chemical
Thrombocytopenia / chemically induced*
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Unraveling the chronic toxicity of lead: an essential priority for environmental health.
Next Document:  Characterization of imidazopyrroloquinoline compounds synthesized from coenzyme PQQ and various amin...